Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Hadfield

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Rhode Island Medical Journal (2013)|January 27, 2026
Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell CarcinomaGrace Sun, Elias O U Eteshola, Matthew J Hadfield, et al.
International Journal of Molecular Sciences|January 11, 2024
Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated ReviewMatthew J Hadfield, Kathryn DeCarli, Kinan Bash, et al.
Cureus|May 29, 2020
A Rare Case of Clear Cell Adenocarcinoma of the Cervix with No Intrauterine Diethylstilbestrol ExposureVinay Mathew Thomas, Swetha Ann Alexander, Matthew J Hadfield, et al.
Best Practice & Research. Clinical Haematology|July 23, 2025
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Poly(ADP-ribose) polymerase inhibitors as cancer therapyJohn F Hilton, Matthew J Hadfield, Minh-Thu Tran, et al.
American Journal of Clinical Oncology|November 21, 2023
Genomic and Molecular Characteristics of Ovarian CarcinosarcomaKristy Ramphal, Matthew J Hadfield, Christina M Bandera, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
Journal of the American Academy of Dermatology|December 26, 2025
Updates in Adjuvant and Neoadjuvant Therapies for Resectable Cutaneous MelanomaMatthew J Hadfield, Sonal Muzumdar, Ryan J Sullivan, et al.
Journal of the American Pharmacists Association : Japha|March 22, 2020
Pharmacist intervention in colorectal cancer screening initiativeLisa M Holle, Joel Levine, Thomas Buckley, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Rhode Island Medical Journal (2013)|January 27, 2026
Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell CarcinomaGrace Sun, Elias O U Eteshola, Matthew J Hadfield, et al.
International Journal of Molecular Sciences|January 11, 2024
Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated ReviewMatthew J Hadfield, Kathryn DeCarli, Kinan Bash, et al.
Cureus|May 29, 2020
A Rare Case of Clear Cell Adenocarcinoma of the Cervix with No Intrauterine Diethylstilbestrol ExposureVinay Mathew Thomas, Swetha Ann Alexander, Matthew J Hadfield, et al.
Best Practice & Research. Clinical Haematology|July 23, 2025
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Poly(ADP-ribose) polymerase inhibitors as cancer therapyJohn F Hilton, Matthew J Hadfield, Minh-Thu Tran, et al.
American Journal of Clinical Oncology|November 21, 2023
Genomic and Molecular Characteristics of Ovarian CarcinosarcomaKristy Ramphal, Matthew J Hadfield, Christina M Bandera, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
Journal of the American Academy of Dermatology|December 26, 2025
Updates in Adjuvant and Neoadjuvant Therapies for Resectable Cutaneous MelanomaMatthew J Hadfield, Sonal Muzumdar, Ryan J Sullivan, et al.
Journal of the American Pharmacists Association : Japha|March 22, 2020
Pharmacist intervention in colorectal cancer screening initiativeLisa M Holle, Joel Levine, Thomas Buckley, et al.
Pageof 4